• Patient-Derived Colorectal Organoids: A Practical Guide

  2026-09-17

  This 2025 protocol paper presents a standardized workflow for generating patient-derived colorectal organoids from normal crypts, polyps, and tumors. Its practical contribution is the integration of tissue processing, crypt isolation, culture establishment, apical-out conversion, immunofluorescence characterization, quality control, and troubleshooting for translational research.

• Docosahexaenoic Acid: From Membrane to Assay

  2026-09-17

  Explore how Docosahexaenoic Acid (DHA) connects membrane biology, neuroprotection research, and oxidation-conscious assay design. This evidence-calibrated guide distinguishes established DHA mechanisms from hypotheses inspired by recent arachidonic acid immunology findings.

• N1-Methylpseudo-UTP: From RNA Design to Translation

  2026-09-16

  N1-Methyl-Pseudouridine-5'-Triphosphate is more than a transcription reagent: it is an upstream variable that can shape RNA structure, stability, translation, and experimental interpretation. This thought-leadership analysis connects modified RNA production with mechanistic lessons from R2 retrotransposon insertion research while defining a practical validation strategy for translational teams.

• A Transient Conformation in Adenine Riboswitch Binding

  2026-09-16

  Wu and colleagues used stopped-flow fluorescence with position-selective RNA labeling to resolve ligand-induced conformational changes in the full-length adenine riboswitch. Their results identify a short-lived intermediate with an unwound P1 helix and show that P1 responds to adenine before the binding pocket and P4, refining models of riboswitch folding and ligand recognition.

• Plk1–p31comet Control of Mitotic Checkpoint Disassembly

  2026-09-15

  The reference study identifies Polo-like kinase 1 as a direct regulator of p31comet, showing that phosphorylation at Ser102 suppresses TRIP13-assisted disassembly of mitotic checkpoint complexes. This mechanism explains how cells avoid simultaneously assembling and dismantling checkpoint complexes during an active spindle assembly checkpoint, and it provides a useful framework for interpreting mitotic kinase perturbation experiments.

• TBXA2R–ERM Signaling in TNBC Metastasis

  2026-09-15

  The reference study identifies TBXA2R as a GPCR that activates ERM cytoskeletal proteins through Gαq/11, Gα12/13, Rho GTPases, and the kinases SLK and LOK. Its findings connect receptor signaling to triple-negative breast cancer motility, invasion, and metastatic colonization, providing a mechanistic framework for studying how GPCRs control metastatic behavior.

• Fluo-4 AM Maps Calcium in Diabetic Nephropathy

  2026-09-14

  A translational framework for using Fluo-4 AM to interrogate the AT1R/Ca2+ axis, validate podocyte mechanisms, and strengthen diabetic nephropathy research beyond a conventional calcium assay.

• ASCC3 Activation in Fragile X Syndrome

  2026-09-14

  A 2025 Science Translational Medicine study identifies ASCC3-dependent ribosome-associated quality control as a previously underappreciated function of FMRP and shows that CRISPR activation of ASCC3 improves molecular, synaptic, and behavioral phenotypes in Fmr1 knockout mice. The work provides a mechanistic rationale for targeting collided-ribosome handling while emphasizing that the approach remains a preclinical proof of concept.

• BI 2536 Workflows for PLK1 Inhibition

  2026-09-13

  BI 2536 enables selective interrogation of PLK1-driven mitotic control, but its greatest value comes from pairing cell-cycle measurements with time-resolved viability and death assays. This workflow connects biochemical potency, cellular response, and tumor xenograft model design while helping researchers avoid common interpretation and solubility errors.

• S-Nitrosylation Coordinates Aluminum Resistance

  2026-09-12

  A 2026 Molecular Plant study identifies nitric oxide–dependent S-nitrosylation as a balancing mechanism that differentially controls STOP1 and STAR1 in Arabidopsis. The findings connect STOP1 degradation, STAR1 stabilization, and the coordination of external and internal aluminum detoxification, while also highlighting the importance of preserving protein abundance during downstream analysis.

• EGCG as a Translational Design Lever in Regeneration

  2026-09-11

  (-)-Epigallocatechin gallate (EGCG) is moving beyond the role of a free antioxidant. This thought-leadership analysis examines how its integration into stimulus-responsive biomaterials can connect redox control, apoptosis biology, and translational delivery strategy in intervertebral disc degeneration research.

• VX-702: p38α MAPK Inhibitor Workflows

  2026-09-11

  VX-702 provides a selective, ATP-competitive route to interrogate p38α MAPK signaling across cytokine, platelet, autoimmune, and cardiac injury models. This workflow-focused guide connects biochemical target engagement with translational readouts while emphasizing solvent control, pathway selectivity, and mechanistic troubleshooting.

• ATG4B, Energy Deficiency, and AML DNA Repair

  2026-09-10

  A 2025 Advanced Science study identifies energy deficiency-induced nuclear translocation of ATG4B as a mechanistic link between altered metabolism, defective PRMT1–MRE11 DNA repair, and acute myeloid leukemia progression. Its combination of mechanistic cellular studies, genetically defined leukemia models, and patient-derived xenografts suggests that ATG4B inhibition may reduce genomic instability and improve disease control, while also highlighting important limits to clinical translation.

• Merimepodib (VX-497) Research Workflows

  2026-09-10

  Merimepodib (VX-497) enables controlled interrogation of IMPDH-dependent guanine nucleotide metabolism across antiviral, lymphocyte, and cancer-model assays. This practical workflow connects PEDV findings with dose design, rescue experiments, metabolite readouts, and troubleshooting for more defensible results.

• Bufalin Workflows for STK33 and TNBC Research

  2026-09-09

  Bufalin combines a cardiotonic steroid scaffold with experimentally useful mechanisms for studying apoptosis, protein degradation, and cancer-cell signaling. This guide translates recent STK33 findings into practical TNBC workflows while separating evidence-backed observations from optimization recommendations.

8507 records 1/568 page Next 12345 下5页 Last page